文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

全球癌症统计数据,2012 年。

Global cancer statistics, 2012.

机构信息

Epidemiologist, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA.

出版信息

CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.


DOI:10.3322/caac.21262
PMID:25651787
Abstract

Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.

摘要

癌症在经济较不发达和较发达的国家都给社会带来了沉重的负担。由于人口的增长和老龄化,以及与城市化和经济发展相关的已确立的风险因素(如吸烟、超重、缺乏身体活动和生育模式的改变)的流行率增加,癌症的发病率也在不断上升。根据 GLOBOCAN 估计,2012 年全球约有 1410 万例新癌症病例和 820 万人死亡。多年来,负担已转移到较不发达国家,这些国家目前占全球病例的约 57%,癌症死亡人数的 65%。在较不发达国家和较发达国家,肺癌都是男性癌症死亡的主要原因,在较发达国家,肺癌已超过乳腺癌成为女性癌症死亡的主要原因;在较不发达国家,乳腺癌仍然是女性癌症死亡的主要原因。在较发达国家,男性和女性的结直肠癌和男性的前列腺癌也是癌症死亡的主要原因。在较不发达国家,男性的肝癌和胃癌以及女性的宫颈癌也是癌症死亡的主要原因。尽管在男性和女性中,较发达国家的所有癌症的综合发病率几乎是较不发达国家的两倍,但较发达国家的死亡率仅比较不发达国家高 8%至 15%。这种差异反映了癌症组合在区域上的差异,这受到风险因素和检测实践的影响,以及/或者治疗的可及性的影响。与癌症主要死亡原因相关的风险因素包括烟草使用(肺癌、结直肠癌、胃癌和肝癌)、超重/肥胖和缺乏身体活动(乳腺癌和结直肠癌)以及感染(肝癌、胃癌和宫颈癌)。广泛应用有效的预防措施,如控烟、疫苗接种和使用早期检测试验,可以预防相当一部分癌症病例和死亡。

相似文献

[1]
Global cancer statistics, 2012.

CA Cancer J Clin. 2015-2-4

[2]
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021-5

[3]
Global cancer statistics.

CA Cancer J Clin. 1999

[4]
[Comparison of the latest cancer statistics, cancer epidemic trends and determinants between China and the United States].

Zhonghua Zhong Liu Za Zhi. 2024-7-23

[5]
[Interpretation on the report of global cancer statistics 2022].

Zhonghua Zhong Liu Za Zhi. 2024-7-23

[6]
Cancer burden estimates and forecasts: uses and cautions.

Tumori. 2013

[7]
Stat bite: Incidence of selected cancers in the developed and developing world.

J Natl Cancer Inst. 2003-11-19

[8]
[Report of Cancer Incidence and Mortality in China, 2014].

Zhonghua Zhong Liu Za Zhi. 2018-1-23

[9]
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Eur J Cancer. 2013-2-26

[10]
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2018-9-12

引用本文的文献

[1]
Antiemetic drug fosaprepitant exerts anti-tumor effects against NSCLC by targeting FAK to inhibit AKT and JNK/c-Jun pathways.

Acta Pharmacol Sin. 2025-9-10

[2]
Epidemiological trends and projections of esophageal cancer in BRICS-plus: Based on the GBD 2021 database.

Front Oncol. 2025-9-1

[3]
Imaging features of appendiceal signet ring cell carcinoma with uterine implantation: A case report.

World J Radiol. 2025-8-28

[4]
MZB1-Driven Endoplasmic reticulum stress model as a predictor of breast cancer progression and survival.

Funct Integr Genomics. 2025-8-29

[5]
Expression Profile of , , , and in Breast Tumors.

Int J Mol Sci. 2025-8-14

[6]
A Comparison of the Flow Cytometric Analysis Results of Benign and Malignant Serous Tumors of the Ovary.

Cancers (Basel). 2025-8-19

[7]
Knowledge, attitudes, and awareness of breast self-examination among female university students in three Arab countries: a multi-center cross-sectional study.

BMC Public Health. 2025-8-27

[8]
UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma.

Front Immunol. 2025-8-11

[9]
Evaluation of cell-free DNA from papanicolaou smears and peripheral blood to detect endometrial cancer.

Front Oncol. 2025-8-11

[10]
Lysyl oxidase as a potential biomarker of lung recurrence after hepatectomy in hepatocellular carcinoma.

Sci Rep. 2025-8-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索